Affiliation:
1. Department of Pharmaceutical Quality Assurance, Dadasaheb Balpande College of Pharmacy, Nagpur, Maharashtra, India.
2. Quest Medpharma Consultants, Nagpur, Maharashtra, India.
Abstract
Nitrosamine impurities in pharmaceutical products have increased attention for safety in the direction of the use of various drugs. Nitrosamines are the class of compounds which represents nitroso group attached to an amine (R1N(-R2)-N=0). Nitrosamines are molecules that have a nitroso group connected to an amine (R1N(-R2)-N=0). Controlling cancer-causing contaminants in pharmaceutical products is critical for predicting and avoiding the carcinogenic risk of medicine in people. According to recent findings, nitrosamine impurities have increased the medicinal product's carcinogenic risk. The literature search was accomplished using PubMed, Google scholar, and the Cochrane library to identify relevant scientific articles using various sensitive techniques and analytical instruments for the detection of nitrosamine impurities from the years 1981 to 2022. The search terms included nitrosamine detection techniques, formation of nitrosamine, HPLC technique for nitrosamine detection, GC-MS/MS, GC-MS/MS, GC-MS-Head space, and GC-QTOF technique for nitrosamine detection, LC-MS/MS technique for nitrosamine detection, The literature search included 29 scientific articles from the English lamnguage, including original research and standard guidelines intended to review all the sensitive techniques for detection of nitrosamine impurities in pharmaceutical products. The current review aims to discuss the highly sensitive, cost effective, accurate and precise methods for the detection of various nitrosamine contaminations in the pharmaceutical products.
Reference30 articles.
1. Tuesuwan B, Vongsutilers V. Nitrosamine contamination in pharmaceuticals: Threat, impact, and control. Journal of Pharmaceutical Sciences. 2021 Sep 1;110(9):3118-28.https://doi.org/10.1016/j.xphs.2021.04.021
2. Control of Nitrosamine Impurities in Human Drugs Guidance for Industry, Introduction, Available at https://www.fda.gov/media/141720/download#:~:text=FDA%20has%20identified%20seven%20nitrosamine,(NDBA)%2C%20and%20N%2D
3. Vyas AJ, Godhaniya JP, et al. A review on carcinogenic impurities found in marketed drugs and strategies for its determination by analytical methods. Asian Journal of Pharmaceutical Analysis. 2021 May 13;11(2):159-69.
4. Zheng J, Kirkpatrick CL, et al. A Full Evaporation Static Headspace Gas Chromatography Method with Nitrogen Phosphorous Detection for Ultrasensitive Analysis of Semi-volatile Nitrosamines in Pharmaceutical Products. The AAPS Journal. 2022 Feb;24(1):1-8. DOI: 10.1208/s12248-021-00669-8
5. Structure of Nitrosamine Drug Impurities and Implications for Chemical Analysis Available at https://acanthusresearch.com/aboutproducts/nitrosamine-impurities-analysis/ accessed date 30th Mar 2022.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献